Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report

por Ogata, Takatsugu, Satake, Hironaga, Ogata, Misato, Hatachi, Yukimasa, Yasui, Hisateru
Publicado 2017

Hyperprogressive Disease in the Irradiation Field after a Single Dose of Nivolumab for Gastric Cancer: A Case Report

por Ogata, Takatsugu, Satake, Hironaga, Ogata, Misato, Hatachi, Yukimasa, Yasui, Hisateru
Publicado 2018

Acute Liver Failure with Diffuse Liver Metastasis from Breast Cancer, Not Detected by Computed Tomography: 2 Case Reports

por Ogata, Takatsugu, Kikawa, Yuichiro, Ogata, Misato, Satake, Hironaga, Hatachi, Yukimasa, Yasui, Hisateru
Publicado 2018

Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation

por Ogata, Misato, Hatachi, Yukimasa, Ogata, Takatsugu, Satake, Hironaga, Imai, Yukihiro, Yasui, Hisateru
Publicado 2018

A simplified method for therapeutic drug monitoring of mitotane by gas chromatography‐electron ionization‐mass spectrometry

por Ando, Motozumi, Hirabatake, Masaki, Yasui, Hisateru, Fukushima, Shoji, Sugioka, Nobuyuki, Hashida, Tohru
Publicado 2020

Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study

por Ogata, Takatsugu, Satake, Hironaga, Ogata, Misato, Hatachi, Yukimasa, Inoue, Kentaro, Hamada, Madoka, Yasui, Hisateru
Publicado 2018

Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine

por Ogata, Misato, Satake, Hironaga, Ogata, Takatsugu, Hatachi, Yukimasa, Hara, Shigeo, Hirota, Seiichi, Yasui, Hisateru
Publicado 2019

First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study

por Satake, Hironaga, Yasui, Hisateru, Kotake, Takeshi, Okita, Yoshihiro, Hatachi, Yukimasa, Kotaka, Masahito, Kato, Takeshi, Tsuji, Akihito
Publicado 2017

Pazopanib-mediated Long-term Disease Stabilization after Local Recurrence and Distant Metastasis of Primary Intracranial Leiomyosarcoma: A Case Report on the Efficacy of Pazopanib...

por Kawabata, Yasuhiro, Aoki, Tomokazu, Yamamoto, Tetsurou, Yasui, Hisateru, Sawai, Satoru, Fukuda, Shunichi, Kawarazaki, Satoru, Tsukahara, Tetsuya
Publicado 2017

Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane

por Satake, Hironaga, Sagawa, Tamotsu, Fujikawa, Koshi, Hatachi, Yukimasa, Yasui, Hisateru, Kotaka, Masahito, Kato, Takeshi, Tsuji, Akihito
Publicado 2018

Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan

por Ogata, Misato, Kotaka, Masahito, Ogata, Takatsugu, Hatachi, Yukimasa, Yasui, Hisateru, Kato, Takeshi, Tsuji, Akihito, Satake, Hironaga
Publicado 2020

Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy

por Ikoma, Tatsuki, Matsumoto, Toshihiko, Kurioka, Yusuke, Takatani, Masahiro, Nagai, Hiroki, Matsumoto, Yusuke, Satake, Hironaga, Yasui, Hisateru
Publicado 2022

Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab

por Matsumoto, Toshihiko, Ikoma, Tatsuki, Yamamura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Nagai, Hiroki, Takatani, Masahiro, Yasui, Hisateru
Publicado 2023

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study

por Ogata, Takatsugu, Satake, Hironaga, Ogata, Misato, Hatachi, Yukimasa, Maruoka, Hayato, Yamashita, Daisuke, Hashida, Hiroki, Hamada, Madoka, Yasui, Hisateru
Publicado 2019

Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan

por Ikoma, Tatsuki, Shimokawa, Mototsugu, Kotaka, Masahito, Matsumoto, Toshihiko, Nagai, Hiroki, Boku, Shogen, Shibata, Nobuhiro, Yasui, Hisateru, Satake, Hironaga
Publicado 2021

Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab

por Matsumoto, Toshihiko, Ikoma, Tatsuki, Yamamura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Nagai, Hiroki, Takatani, Masahiro, Yasui, Hisateru
Publicado 2023

Salient Features and Outline of the Joint Japanese Guidelines for Safe Handling of Cancer Chemotherapy Drugs

por Kanda, Kiyoko, Hirai, Kazue, Iino, Keiko, Nomura, Hisanaga, Yasui, Hisateru, Kano, Taro, Ichikawa, Chisato, Hiura, Sumiko, Morita, Tomoko, Mitsuma, Ayako, Komatsu, Hiroko
Publicado 2017

Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study

por Kikawa, Yuichiro, Hatachi, Yukimasa, Rumpold, Gerhard, Tokiwa, Mariko, Takebe, Sayaka, Ogata, Takatsugu, Satake, Hironaga, Kato, Hironori, Tsuji, Akihito, Yasui, Hisateru, Holzner, Bernhard
Publicado 2018

Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection

por Kotake, Takeshi, Satake, Hironaga, Okita, Yoshihiro, Hatachi, Yukimasa, Hamada, Mamiko, Omiya, Masatomo, Yasui, Hisateru, Hashida, Toru, Kaihara, Satoshi, Inokuma, Tetsuro, Tsuji, Akihito
Publicado 2018

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

por Nishina, Tomohiro, Takano, Yoshinao, Denda, Tadamichi, Yasui, Hisateru, Takeda, Koji, Ura, Takashi, Esaki, Taito, Okuyama, Yusuke, Kondo, Ken, Takahashi, Yasuo, Sugiyama, Yasuyuki, Muro, Kei
Publicado 2013